Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sutent Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Sutent Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Sutent Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Submitted by
admin
on May 21, 2011 - 11:11am
Source:
Yahoo/BusinessWire
News Tags:
Sutent
neuroendocrine tumors
Pfizer
Headline:
Sutent Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Do Not Allow Advertisers to Use My Personal information
